Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/53295
Title: Survivorship care plan utilization in Australia and New Zealand: survivors', parents' and healthcare providers' perspectives.
Authors: Hill R.E.;Fardell J.E.;Mercieca-Bebber R.;Wakefield C.E.;Signorelli C.;Webber K. ;Johnston K.A.;Cohn R.J.
Monash Health Department(s): Monash University - School of Clinical Sciences at Monash Health
Oncology
Institution: (Hill, Fardell, Wakefield, Signorelli, Johnston, Cohn) School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, Randwick, NSW, Australia
(Hill, Fardell, Wakefield, Signorelli, Johnston, Cohn) Kids Cancer Centre, Behavioural Sciences Unit, Sydney Children's Hospital, Sydney, NSW, Australia
(Mercieca-Bebber) Trials Centre, NHMRC Clinical, The University of Sydney, Sydney, NSW, Australia
(Webber) School of Clinical Sciences at Monash Health, Faculty of Medicine, Monash University, Monash, VIC, Australia
(Webber) Medical Oncology Department, Monash Health, Clayton, VIC, Australia
Issue Date: 25-Feb-2025
Copyright year: 2025
Publisher: Springer Science and Business Media Deutschland GmbH
Place of publication: Germany
Publication information: Supportive Care in Cancer. 33(3) (no pagination), 2025. Article Number: 182. Date of Publication: 01 Mar 2025.
Journal: Supportive Care in Cancer
Abstract: Purpose: As part of survivorship care, many health authorities recommend survivorship care plans (SCPs). The aim of this study was to understand survivors' SCP receipt and use, clinical/demographic factors associated with use, and providers' SCP practices. Method(s): We surveyed Australian and New Zealand survivors of adult and childhood cancer (including parent proxies for survivors aged < 16 years). We fitted binomial logistic regression models to examine the relationship between survivors' clinical and sociodemographic characteristics, and SCP receipt. We also surveyed oncology health providers regarding current SCP provision practices, perceived receipt, and usefulness. Result(s): We recruited 1123 cancer survivors (499 adult cancer survivors and 624 childhood cancer survivors, including 222 parent proxies) and 21 healthcare providers. 10.7% of adult and 22.0% of childhood cancer survivors recalled receiving SCPs. SCP receipt was more likely for adult cancer survivors diagnosed with prostate cancer, low-risk cancer diagnoses and older at study participation, and childhood cancer survivors treated with chemotherapy or younger at study participation. Across both groups, a higher level of education attainment was predictive of SCP use. Most healthcare providers estimated that < 15% of adult and > 75% of childhood cancer survivors received SCPs. Conclusion(s): Few survivors of adult or childhood cancer reported receiving a SCP, and there were sociodemographic and clinical differences in those who did and did not receive and use their SCP. SCP recipients used and valued them, but healthcare providers indicated potential areas for improvement with SCP provision. Consideration may be needed regarding SCP format, presentation and content.Copyright © The Author(s) 2025.
DOI: http://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1007/s00520-025-09238-7
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/53295
Type: Article
Subjects: childhood cancer survivor
prostate cancer
radiotherapy
Type of Clinical Study or Trial: Qualitative study
Appears in Collections:Articles

Show full item record

Page view(s)

8
checked on Mar 8, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.